Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPets at home Regulatory News (PETS)

Share Price Information for Pets at home (PETS)

Share Price is delayed by 15 minutes
Get Live Data
183.40    -2.40 (-1.29%)
Bid:
182.00
Ask:
184.10
Spread: 2.10 (1.154%)
Market Cap: £811.14m
PETS Live PriceLast checked at - London Stock Exchange

Intraday Pets at home Share Chart

Director/PDMR Shareholding

15 Jun 2017 14:34

RNS Number : 2300I
Pets At Home Group Plc
15 June 2017
 

Pets at Home Group Plc

(the 'Company')

 

Notifications of transactions by Directors/ Persons Discharging Managerial

Responsibilities and Person Closely Associated

 

 

1

Details of the person discharging managerial responsibilities/director

 

a)

Name

 

Michael Iddon

2

Reason for the notification

 

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Pets at Home Group Plc

b)

LEI

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type

of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial

instrument, type of instrument

 

 

Identification code

Ordinary shares of 1 pence each in Pets at Home Group Plc

 

 

 

ISIN GB00BJ62K685

 

b)

Nature of the Transaction

The transfer of 45,996 ordinary shares in the Company to Person Closely Associated, Allison Iddon

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

N/A

45,996

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

Price

 

Aggregated volume

Aggregate Total

N/A

Single Transaction

Only

 

e)

Date of Transaction

11th June 2017

f)

Place of Transaction

London Stock Exchange (XLON)

 

 

 

1

Details of the person closely associated

 

a)

Name

 

Allison Iddon

2

Reason for the notification

 

a)

Position/status

Person Closely Associated

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Pets at Home Group Plc

b)

LEI

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type

of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial

instrument, type of instrument

 

 

Identification code

Ordinary shares of 1 pence each in Pets at Home Group Plc

 

 

 

ISIN GB00BJ62K685

 

b)

Nature of the Transaction

The receipt of 45,996 ordinary shares in the Company from Director, Michael Iddon

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

N/A

522,875

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

Price

 

Aggregated volume

Aggregate Total

N/A

Single Transaction

Only

 

e)

Date of Transaction

11th June 2017

f)

Place of Transaction

London Stock Exchange (XLON)

 

This Notification is made in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

For Further information and for the persons responsible for arranging the release of this announcement, please contact;

 

Louise Stonier

Chief People and Legal Officer and Company Secretary

Pets at Home Group Plc

Epsom Avenue

Stanley Green Trading Estate

Handforth

Cheshire

SK9 3RN

Tel: 0161 486 3590

Email: companysecretary@petsathome.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHOKPDNNBKDNAD
Date   Source Headline
27th May 20267:00 amRNSFY26 Preliminary Results
8th Apr 20261:47 pmRNSHolding(s) in Company
8th Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSFY26 pre-close statement
3rd Mar 20267:00 amRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTotal Voting Rights
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSQ3 FY26 Trading Statement
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSConfirmation of Board Changes
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
23rd Dec 20257:00 amRNSAppointment of CEO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.